Pharmacodynamic Effects of a 6-Hour Regimen of Enoxaparin in Patients Undergoing Primary Percutaneous Coronary Intervention (PENNY PCI Study)

von Sumaya, Wael, Parker, William A. E., Fretwell, Rebekah, Hall, Ian R., Barmby, David S., Richardson, James D., Iqbal, Javaid, Adam, Zulfiquar, Morgan, Kenneth P., Gunn, Julian P., Mason, Annah E., Judge, Heather M., Gale, Christopher P., Ajjan, Ramzi A., Storey, Robert F.
Veröffentlicht in Thromb Haemost (2018)